Skip to content

Impact of Suppressing Surgical Stress Reaction on Postoperative Inflammation.

Observational Study Evaluating the Impact of Surgical Stress Suppression During Opioid Free Anesthesia on Postoperative Inflammation During Major Surgery.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04195009
Enrollment
100
Registered
2019-12-11
Start date
2019-12-01
Completion date
2021-12-31
Last updated
2019-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Postoperative Pain

Brief summary

Patients undergoing surgery under opioid free general anesthesia (OFA) are monitored with antinociceptive devices like NOL or ANI that measures sympathetic activity but are invisible for the attending anesthesiologist . Observational study comparing patients with sufficient suppression of sympathetic reactions with patients having insufficient suppression on hemodynamic stability, post operative sedation, pain and inflammatory markers.

Detailed description

all patients get an opioid free anesthesia using dexmedetomidine, lidocaine, ketamine and magnesium. dosing is according to the attending anesthesiologist. total dose of each drug and duration of anesthesia are recorded. Antinociceptive devices measures how long the patient is during anesthesia having a nociceptive level nociception level index (NOL) or Analgesia Nociception Index (ANI) above normal without showing the data to the attending anesthesiologist. Relationship is calculated between on one side the hemodynamic stability, postoperative sedation, pain, postoperative CRP and on the other side the time NOL is above 20 or ANI is below 50.

Interventions

PROCEDUREmajor surgery under opioid free anesthesia without regional anesthesia

measuring nociception in every patient but blinded for attending anesthesiologist

Sponsors

AZ Sint-Jan AV
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* major surgical procedures without need for regional anesthesia

Exclusion criteria

* allergy to one of the anesthetics used * major liver, renal cardiac or pulmonary disease reducing normal function

Design outcomes

Primary

MeasureTime frameDescription
CRP 24 hours postoperative24 hours postoperativemeasure chronic reactive protein (CRP) biomarker of surgical inflammation

Secondary

MeasureTime frameDescription
hemodynamic stabilityintraoperativedosis of vasoactive drugs needed to support blood pressure before blood pressure rise as requested by surgeons.
postoperative pain using VAS scoreup to 4 hours postoperative during post anesthetic care unit (PACU) staypostoperative pain measured by visual analog scale (VAS) score: max pain =10 and worst, no pain = 0
postoperative sedation using Ramsay scorefirst 4 hours postoperative during PACU staydeepest postoperative sedation level measured by the Ramsay score at the PACU full awake or no sedation = 1 deep sleep or anesthesia = 5 and worst
postoperative opioids usedfirst 24 hours postoperativetotal amount of opioids needed postoperative

Countries

Belgium

Contacts

Primary ContactJan Paul Mulier, MD PhD
jan.mulier@azsintjan.be+32486729203
Backup ContactJoke Denolf
joke.denolf@azsintjan.be003250452193

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026